Healthcare-associated pneumonia in hospitalized patients in South Korea
Author Information
Author(s): Jung Ji Ye, Park Moo Suk, Kim Young Sam, Park Byung Hoon, Kim Se Kyu, Chang Joon, Kang Young Ae
Primary Institution: Yonsei University College of Medicine
Hypothesis
What are the differences between healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP) in terms of clinical features, pathogens, and outcomes?
Conclusion
Patients with healthcare-associated pneumonia (HCAP) showed higher rates of potentially drug-resistant pathogens and worse clinical outcomes compared to those with community-acquired pneumonia (CAP).
Supporting Evidence
- HCAP patients had a higher in-hospital mortality rate of 28.1% compared to 10.8% for CAP patients.
- Potentially drug-resistant bacteria were found in 12.6% of HCAP patients versus 4.7% in CAP patients.
- Tube feeding and prior hospitalization with antibiotic treatment were significant risk factors for PDR pathogens.
Takeaway
This study found that patients with healthcare-associated pneumonia are more likely to have serious infections and need stronger antibiotics than those with regular pneumonia.
Methodology
A retrospective observational study of 527 hospitalized patients with HCAP or CAP conducted at Severance Hospital in South Korea.
Potential Biases
Potential bias due to the retrospective nature and limited data on prior antibiotic use.
Limitations
The study was retrospective, conducted in a single institution, and had a low proportion of identified pathogens.
Participant Demographics
Patients included 231 with HCAP and 296 with CAP, with a mean age of 63.5 years for HCAP.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI 4.62-48.31
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website